Risks of Online Direct-to-Consumer Tumor Markers for Cancer Screening
Cet article passe en revue les risques associés à la vente directe de marqueurs tumoraux pour le dépistage des cancers
Cancer is the leading cause of death worldwide. Given the emotional impact of a potential cancer diagnosis, patients often search for methods
of early detection. Moreover, with a growing direct-to-consumer (DTC) industry advertising medical products online, patients are increasingly empowered to seek out cancer diagnoses and treatments without qualified medical guidance. Indeed, a 2005 National Cancer Institute survey found 50% of respondents would seek online cancerrelated information before physician consultation. Yet, problematically, studies have highlighted fraudulent claims made by online DTC medical product marketing as well as dangers associated with various disease-based DTC screening tests. These concerns have expanded to cancer. (...]
Journal of Clinical Oncology , article en libre accès, 2012